Today’s customers expect businesses to deliver positive social, environmental and financial outcomes. Ensuring what you do helps and doesn’t hinder. Broader sustainable development goals is an increasingly pressing issue. B Corporation certification (assessed by the not-for-profit B Lab) is given to for-profit organisations who achieve at least a minimum score against a set of social and environmental standards.
Adopting Responsible Technology
The model of human and economic development, developed during past industrial revolutions, has largely come at the expense of the planet. Our climate, water, air, biodiversity, forests and oceans are under increasing strain. Making the 4IR a sustainable revolution is the opportunity of this generation. The systems change required to deliver a clean, resource-secure and inclusive economy can be enabled by technology and supported by public policy and investment. As artificial intelligence (AI) is emerging as the defining technology of our age, with many industries already utilising AI in some form. The rapid advancement of technology has made it necessary to change business models, change how you relate to your customers, and change the structure and design of your organisation.
Innovation for The Earth
We set out how the 4th Industrial Revolution, and in particular Artificial Intelligence (AI), can help solve environmental challenges, from climate change to biodiversity. In collaboration with the World Economic Forum, we discuss how AI ethics and safety needs to be extended to include “Earth-friendly” AI.
As AI becomes more sophisticated, more and more decision making is being performed by an algorithmic ‘black box’. To have confidence in the outcomes, cement stakeholder trust and ultimately capitalise on the opportunities, it may be necessary to know the rationale of how the algorithm arrived at its recommendation or decision – ‘Explainable AI’.
There are significant business benefits of building interpretability into AI systems. As well as helping address pressures such as regulation, and adopt good practices around accountability and ethics, there are significant benefits to be gained from being on the front foot and investing in explainability today.
The AI Opportunity for the Environment
The 6 priority action areas and successfully addressing them
Automation and Jobs
Governments and business need to work together to help people adjust to these new technologies through retraining and career changes. A culture of adaptability and lifelong learning will be crucial for spreading the benefits of AI and robotics widely through society, particularly with an ageing population where we need people to be able to work for longer.
PatientMetRx & Tech for Good
We have not been afraid to challenge Pharmaceutical Companies who have had a blind spot toward real world patient experience. Health has never been more important to the public and with 50% of medicines not taken as prescribed there is huge inefficiency which needs to be address through transformations within healthcare and medicine marketing. PatientMetRx is an AI driven “data insights as a service” Company. Its primary purpose is to sell data subscriptions for its service PatientMetRx to Marketeers within global Pharmaceutical Companies. It’s unique selling point is the proprietary AI tools and insights collected about how patients take their own medicines in the real world.
PatientMetRx impact is aligned to its customer global footprint. The key stakeholders for Talking Medicines are:
- Patients/Consumers talking about their medicines in public places.
- Pharmaceutical Companies who manufacture and market key drugs
- There are 130,000 regulated drugs and the 500 key Pharmaceutical Companies operate across the globe. $30Bn is spend on marketing drugs, and PatientMetRx want to drive efficiency in this spend to support patients.
Our product PatientMetRx engages with everyday people to capture data – data for good. At the heart of our digital patient listening products is our curated medicines database. We have over 25K community medicines which we have built with regulatory bodies to the highest quality. We capture data in a safe, compliance and ethical way – we aggregate patters of behaviours on how people are actually taking their medicines. We sell our aggregated patient data through an annual subscription model.
68% of Pharmaceutical marketeers keen to gain access to real work patient data on how medicines are actually being taken in the real world once they leave the pharmacy there is a market for our data.
To find out more about our product and how we provide technology for good, visit our website or book a call with the team using the link below:
Pwc (2021) Artificial Intelligence everywhere. Available at: https://www.pwc.co.uk/issues/data-analytics/artificial-intelligence.html [Accessed 4 May 2021]